NPS MedicineWise has welcomed the budget’s four years of Commonwealth funding for the continuation of its work to improve quality use of medicines and medical tests.
“Quality use of medicines and medical tests remains a cornerstone of quality healthcare and we’re pleased the Australian government has reaffirmed its ongoing commitment and support for our work,” NPS MedicineWise CEO Dr Lynn Weekes said.
“We welcome longer-term funding certainty and will work closely with the Department of Health to determine key priorities and deliverables for the next four years.”
NPS MedicineWise has also acknowledged and welcomed the “substantial” investment across the health portfolio, particularly in relation to the Medicare Benefits Schedule (MBS) and PBS.
NPS says it is celebrating 20 years of leading quality use of medicines in Australia this year. It adds that its work contributes to the sustainability of the PBS and MBS and that, since its inception, programs have delivered more than $1 billion in savings along with demonstrable improvement in health outcomes for Australians.